Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus

D. T. Rodgers, M. A. Pineda, C. J. Suckling, W. Harnett, M. M. Harnett^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

26 Citations (Scopus)

97 Downloads (Pure)

1 results

Finished
The Filarial Nematode Immunomodulator Es-62 As A Tool In Novel Drug Development For Mast Cell-Dependent Inflammatory Diseases
Harnett, W. (Principal Investigator)
Wellcome Trust
1/05/09 → 31/08/15
Project: Research